Thomas Hager

Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape

Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning

Convolutional neural networks can accurately distinguish four histologic growth patterns of lung adenocarcinoma in digital slides

Factors influencing the concordance of histological subtype diagnosis from biopsy and resected specimens of lung adenocarcinoma

Macrophages in immunoregulation and therapeutics

Use of Immunotherapy and Radiation Treatment in the Management of Metastatic Melanoma With Rhabdomyosarcomatous Differentiation

High-performance medicine: the convergence of human and artificial intelligence

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Deep learning in histopathology: the path to the clinic

EGFR,KRAS,BRAFandALKgene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype

Cisplatin resistance and opportunities for precision medicine

Targeting ferroptosis as a vulnerability in cancer

Artificial intelligence in healthcare

Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features

The side effects of platinum-based chemotherapy drugs: a review for chemists

Smart wound dressings for wound healing

Methodologic Guide for Evaluating Clinical Performance and Effect of Artificial Intelligence Technology for Medical Diagnosis and Prediction

Biological Mechanisms and Clinical Significance of BAP1 Mutations in Human Cancer

Natural product and natural product derived drugs in clinical trials

Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection

N -Chloramines, a Promising Class of Well-Tolerated Topical Anti-Infectives

N‐chlorotaurine and its analoguesN,N‐dichloro‐2,2‐dimethyltaurine andN‐monochloro‐2,2‐dimethyltaurine are safe and effective bactericidal agents inex vivocorneal infection models

Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro

ERCC1, MLH1, MSH2, MSH6, and βIII-Tubulin: Resistance Proteins Associated With Response and Outcome to Platinum-based Chemotherapy in Malignant Pleural Mesothelioma

Training increases concordance in classifying pulmonary adenocarcinomas according to the novel IASLC/ATS/ERS classification

Tumour cell PD-L1 expression is prognostic in patients with malignant pleural effusion: the impact of C-reactive protein and immune-checkpoint inhibition

Metastatic Malignant Melanoma With Complete Loss of Differentiation Markers (Undifferentiated/Dedifferentiated Melanoma)

Comparing the Prognostic Value of BAP1 Mutation Pattern, Chromosome 3 Status, and BAP1 Immunohistochemistry in Uveal Melanoma